From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis
- 15 January 2008
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (2), 576-585
- https://doi.org/10.1016/j.bmcl.2007.11.067
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar PotencyJournal of Medicinal Chemistry, 2005
- Chemokine receptor antagonists: a novel therapeutic approach in allergic diseasesAllergy, 2004
- Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic DiseaseCurrent Drug Targets - Inflammation & Allergy, 2002
- Chemokine Receptors in Airway Disease: Which Receptors to Target?Pulmonary Pharmacology & Therapeutics, 2001
- CCR3 blockade as a new therapy for asthmaExpert Opinion on Investigational Drugs, 2000
- Preparation of Aminoalkyl Chlorohydrin Hydrochlorides: Key Building Blocks for Hydroxyethylamine-Based HIV Protease InhibitorsThe Journal of Organic Chemistry, 1996
- Asymmetric synthesis of β-amino-α-hydroxy acids via diastereoselective hydroxylation of homochiral β-amino enolatesJournal of the Chemical Society, Perkin Transactions 1, 1994
- Chemistry of oxaziridines. 18. Synthesis and enantioselective oxidations of the [(8,8-dihalocamphoryl)sulfonyl]oxaziridinesThe Journal of Organic Chemistry, 1992
- Allylic 1,3-strain as a controlling factor in stereoselective transformationsChemical Reviews, 1989